A multicenter clinical study for Yiqi Tongluo Granule in the treatment of angina pectoris caused by non obstructive coronary microvascular disease
- Conditions
- Angina pectoris
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Have symptoms of myocardial ischemia, such as exertive or resting angina;
(2) ECG changes or exercise load test were positive during the attack;
(3) No stenosis more than 50% was found by coronary angiography;
(4) D-spect evaluation CFR < 2; aged 40-80 years, gender unlimited;
(5) The syndrome differentiation of TCM is Qi deficiency and blood stasis.
(6) Patients and their families are willing to cooperate and meet the exclusion criteria.
(1) Grade 4 cardiac function or pulmonary edema;
(2) Severe primary brain and lung diseases and liver and kidney dysfunction;
(3) Allergic to traditional Chinese medicine;
(4) Patients with malignant diseases;
(5) Severe inflammatory disease;
(6) patients with bleeding diseases;
(7) malignant arrhythmia;
(8) acute coronary syndrome;
(9) Mental patients;
(10) Pregnant or nursing women;
(11) Those who participated in other clinical trials within the past month.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method